Patent FR1139728A successfully refreshed from Google Patents.
Patent US5874219A successfully refreshed from Google Patents.
US5874219A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methods for concurrently processing multiple biological chip assays
Assignee: Affymetrix Inc
•
Filing: 1996-04-09
•
Granted: 1999-02-23
•
Expires: 2016-04-09
Abstract
Abstract Methods for concurrently processing multiple biological chip assays by providing a biological chip plate comprising a plurality of test wells, each test well having a biological chip having a molecular probe array; introducing samples into the test wells; subjecting the biological chip plate to manipulation by a fluid handling device that automatically performs steps to carry out reactions between target molecules in the samples and probes; and subjecting the biological chip plate to a biological chip plate reader that interrogates the probe arrays to detect any reactions between target molecules and probes.
Inventors
- 👤 Richard P. Rava
- 👤 Stephen P.A. Fodor
- 👤 Mark Trulson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 14:38
CPC Classifications
G; G01; G01N; G01N35/00; G01N35/02; G01N35/028; B; B01; B01J; B01J19/00; B01J19/0046; B01L; B01L3/00; B01L3/50; B01L3/508; B01L3/5085; C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6834; C12Q1/6837; B01J2219/00; B01J2219/00274; B01J2219/00277; B01J2219/00279; B01J2219/00306; B01J2219/00313; B01J2219/00315; B01J2219/00317; B01J2219/00351; B01J2219/00427; B01J2219/00432; B01J2219/00497; B01J2219/00527; B01J2219/00529; B01J2219/00583; B01J2219/00603; B01J2219/00605; B01J2219/00608; B01J2219/0061; B01J2219/00612; B01J2219/00614; B01J2219/00617; B01J2219/00621; B01J2219/00623; B01J2219/00626; B01J2219/00632; B01J2219/00637; B01J2219/00659; B01J2219/00662; B01J2219/0068; B01J2219/00702; B01J2219/00707; B01J2219/00718; B01J2219/0072; B01J2219/00722; B01L2300/00; B01L2300/06; B01L2300/0627; B01L2300/0636; B01L2300/08; B01L2300/0809; B01L2300/0829; C40; C40B; C40B40/00; C40B40/04; C40B40/06; C40B60/00; C40B60/14; G01N21/00; G01N21/62; G01N21/63; G01N21/64
Claims Analysis
Total Claims: 79
Claim 1
Independent Claim
141 words
A method for concurrently processing multiple biological chip assays comprising the steps of: (a) providing a biological chip plate comprising a contiguous substrate that comprises a contiguous surface and, attached to the contiguous surface, a plurality of probe arrays and, surrounding the probe arrays, material resistant to the flow of liquid thereby forming a plurality of test wells, each test well defining a space for the introduction of a sample; (b) manipulating the biological chip plate with a fluid handling device that automatically performs steps to carry out reactions between target molecules in a test sample and probes in a plurality of the test wells; and (c) interrogating the probe arrays of the biological chip plate with a biological chip plate reader to detect reactions between target molecules and probes in a plurality of the test wells to generate assay results.
Claim 2
Independent Claim
141 words
A method for concurrently processing multiple biological chip assays comprising the steps of: (a) providing a biological chip plate comprising a contiguous substrate that comprises a contiguous surface and, attached to the contiguous surface, a plurality of probe arrays and, surrounding the probe arrays, material resistant to the flow of liquid thereby forming a plurality of test wells, each test well defining a space for the introduction of a sample; (b) manipulating the biological chip plate with a fluid handling device that automatically performs steps to carry out reactions between target molecules in a test sample and probes in a plurality of the test wells; and (c) interrogating the probe arrays of the biological chip plate with a biological chip plate reader to detect reactions between target molecules and probes in a plurality of the test wells to generate assay results.
Claim 3
Dependent Claim
16 words
The method of claim 1 further comprising the step of processing the results with a computer.
Claim 4
Dependent Claim
32 words
The method of claim 2 wherein the results are processed into an image with the intensity in each region of the image varying according to the binding affinity between targets and probes.
Claim 5
Dependent Claim
13 words
The method of claim 1 wherein the probes are DNA or RNA molecules.
Claim 6
Dependent Claim
30 words
The method of claim 4 wherein (a) the reactions are hybridization of target molecules to probes; and (b) the results provide information regarding the nucleotide sequence of the target molecule.
Claim 7
Dependent Claim
17 words
The method of claim 5 wherein the assay is the detection or identification of a pathogenic organism.
Claim 8
Dependent Claim
11 words
The method of claim 6 wherein the pathogenic organism is HIV.
Claim 9
Dependent Claim
18 words
The method of claim 5 wherein the assay is the detection or identification of a human nucleic acid.
Claim 10
Dependent Claim
16 words
The method of claim 8 wherein the assay is the detection of a human gene variant.
Claim 11
Dependent Claim
24 words
The method of claim 8 wherein the human gene variant indicates the existence of, or predisposition to cystic fibrosis, diabetes, muscular dystrophy or cancer.
Claim 12
Dependent Claim
36 words
The method of claim 1 wherein the assay is the identification of a probe in a library that binds to a receptor and the reaction is the binding of a target molecule to a peptide probe.
Claim 13
Dependent Claim
20 words
The method of claim 1 wherein the reaction is the catalytic transformation of a probe molecule by a target catalyst.
Claim 14
Dependent Claim
29 words
The method of claim 1 further comprising controlling the temperature of the samples in the test wells and adding or removing fluids from the test wells at predetermined times.
Claim 15
Dependent Claim
26 words
The method of claim 1 wherein the target molecule is tagged with a fluorescent marker, a chemiluminescent marker, a light scattering marker or a radioactive marker.
Claim 16
Dependent Claim
22 words
The method of claim 14 wherein the marker is a fluorescent marker selected from the group consisting of fluorescein, rhodamine, or cyanine.
Claim 17
Dependent Claim
75 words
The method of claim 1 wherein the fluid handling device and the biological chip plate reader comprise (a) a confocal detection device having a monochromatic or polychromatic light source; (b) optics for directing an excitation light from the light source at the substrate; (c) a temperature controller for controlling temperature of the substrate during a reaction; and (d) a detector for detecting fluorescence emitted by a fluorescently labelled molecule in response to the excitation light.
Claim 18
Dependent Claim
25 words
The method of claim 1 wherein the manipulating step comprises robotically controlling pipets for adding or removing fluids from the test wells at predetermined times.
Claim 19
Dependent Claim
12 words
The method of claim 16 wherein the detector comprises a photomultiplier tube.
Claim 20
Dependent Claim
29 words
The method of claim 16 wherein the interrogating step comprises focusing the excitation light to a point on the plate and determining the region from which the fluorescence originated.
Claim 21
Dependent Claim
24 words
The method of claim 16 wherein the target is tagged with a fluorescent marker and the biological chip plate reader comprises a CCD array.
Claim 22
Dependent Claim
16 words
The method of claim 1 wherein the probe arrays each have at least about 2500 features.
Claim 23
Dependent Claim
16 words
The method of claim 1 wherein the probe arrays each have at least about 50,000 features.
Claim 24
Dependent Claim
14 words
The method of claim 1 wherein each test well comprises an individual probe array.
Claim 25
Dependent Claim
25 words
The method of claim 1 wherein said chip plate is made by the steps of mating a wafer to an array of open ended wells.
Claim 26
Dependent Claim
14 words
The method of claim 5, wherein the samples are from a plurality of patients.
Claim 27
Dependent Claim
27 words
The method of claim 25 further comprising the step of using information from the results to determine which of the patients exhibit a genetic disease or characteristic.
Claim 28
Dependent Claim
34 words
The method of claim 1 wherein the interrogating step comprises the steps of: (a) directing excitation light through a bottom surface of said plate; and (b) detecting where targets bound on said probe arrays.
Claim 29
Dependent Claim
15 words
The method of claim 1 wherein the probe arrays are produced by light-directed probe synthesis.
Claim 30
Dependent Claim
25 words
The method of claim 1 wherein the interrogating step comprises determining the on- or off-rates of binding between target molecules in a sample and probes.
Claim 31
Independent Claim
126 words
A system for concurrently processing multiple biological chip assays comprising: (a) a biological chip plate comprising a contiguous substrate that comprises a contiguous surface and, attached to the contiguous surface, a plurality of probe arrays and, surrounding the probe arrays, material resistant to the flow of liquid thereby forming a plurality of test wells, each test well defining a space for the introduction of a sample; (b) a fluid handling device that automatically performs steps to carry out reactions between target molecules in the samples and probes in a plurality of the test wells; and (c) a biological chip plate reader that interrogates the probe arrays to detect any reactions between target molecules and probes in a plurality of the test wells to produce assay results.
Claim 32
Independent Claim
126 words
A system for concurrently processing multiple biological chip assays comprising: (a) a biological chip plate comprising a contiguous substrate that comprises a contiguous surface and, attached to the contiguous surface, a plurality of probe arrays and, surrounding the probe arrays, material resistant to the flow of liquid thereby forming a plurality of test wells, each test well defining a space for the introduction of a sample; (b) a fluid handling device that automatically performs steps to carry out reactions between target molecules in the samples and probes in a plurality of the test wells; and (c) a biological chip plate reader that interrogates the probe arrays to detect any reactions between target molecules and probes in a plurality of the test wells to produce assay results.
Claim 33
Dependent Claim
17 words
The system of claim 30 further comprising a computer comprising a program for processing the assay results.
Claim 34
Dependent Claim
13 words
The system of claim 30 wherein the probes are DNA or RNA molecules.
Claim 35
Dependent Claim
71 words
The system of claim 30 wherein the fluid handling device and the biological chip plate reader comprise (a) a confocal detection device having a monochromatic or polychromatic light source; (b) means for directing an excitation light from the light. source at the substrate; (c) means for controlling temperature of the substrate during a reaction; and (d) means for detecting fluorescence emitted by fluorescently labelled molecules in response to the excitation light.
Claim 36
Dependent Claim
93 words
The system of claim 33 wherein the fluid handling device comprises robotically controlled pipets for adding or removing fluids from the test wells at predetermined times; and wherein (a) the means for detecting the fluorescent emissions from the substrate comprise a photomultiplier tube; (b) the means for focusing the excitation light to a point on the substrate and determining the region from which the fluorescence originated comprise an x-y-z translation table; and (c) wherein translation of the x-y-z translation table, temperature control and data collection are managed and recorded by a digital computer.
Claim 37
Dependent Claim
33 words
The system of claim 33 wherein the means for directing excitation light and means for detecting are arranged to illuminate and read the test wells through a bottom side of the test wells.
Claim 38
Dependent Claim
15 words
The system of claim 30 wherein the biological chip plate reader comprises a line scanner.
Claim 39
Dependent Claim
15 words
The system of claim 30 wherein the biological chip plate reader comprises a CCD array.
Claim 40
Dependent Claim
15 words
The system of claim 30 wherein each probe array has at least about 2500 features.
Claim 41
Dependent Claim
15 words
The system of claim 30 wherein each probe array has at least about 50,000 features.
Claim 42
Dependent Claim
15 words
The system of claim 30 wherein the biological chip plate comprises about 96 test wells.
Claim 43
Dependent Claim
49 words
A biological chip plate comprising a contiguous substrate that comprises on its surface a plurality of probe arrays and, surrounding the probe arrays, material resistant to the flow of liquid thereby forming a plurality of test wells, each test well defining a space for the introduction of a sample.
Claim 44
Dependent Claim
49 words
A biological chip plate comprising a contiguous substrate that comprises on its surface a plurality of probe arrays and, surrounding the probe arrays, material resistant to the flow of liquid thereby forming a plurality of test wells, each test well defining a space for the introduction of a sample.
Claim 45
Dependent Claim
28 words
The biological chip plate of claim 41 wherein the substrate comprises functionalized glass or silica comprising Si, Ge, GaAs, GaP, SiO 2 , SiN 4 or modified silicon.
Claim 46
Dependent Claim
35 words
The biological chip plate of claim 41 wherein the surface comprises polymers, plastics, resins, polysaccharides, silica or silica-based materials, carbon, metals, inorganic glasses, membranes, polymerized Langmuir Blodgett film, functionalized glass, (poly)tetrafluoroethylene, (poly)vinylidenedifluoride, polystyrene or polycarbonate.
Claim 47
Dependent Claim
22 words
The biological chip plate of claim 41 comprising a body having test wells, wherein each test well comprises an individual probe array.
Claim 48
Dependent Claim
19 words
The biological chip plate of claim 44 wherein the body comprises (poly)tetrafluoroethylene, (poly)vinylidenedifluoride, polypropylene, polystyrene, polycarbonate, or combinations thereof.
Claim 49
Dependent Claim
69 words
The biological chip plate of claim 41 comprising a wafer and a body, the wafer comprising a plurality of probe arrays and the body comprising a plurality of channels, wherein the body is attached to the surface of the wafer so that a plurality of the channels each cover a probe array and the wafer closes one end of a plurality of the channels, thereby forming the test wells.
Claim 50
Dependent Claim
19 words
The biological chip plate of claim 46 wherein the body comprises (poly)tetrafluoroethylene, (poly)vinylidenedifluoride, polypropylene, polystyrene, polycarbonate, or combinations thereof.
Claim 51
Dependent Claim
32 words
The biological chip plate of claim 41 comprising a wafer having a plurality of probe arrays and a material resistant to the flow of a liquid sample that surrounds each probe array.
Claim 52
Dependent Claim
14 words
The biological chip plate of claim 48 wherein the material is a hydrophobic material.
Claim 53
Dependent Claim
17 words
The biological chip plate of claim 41 comprising 96 wells arranged in 8 rows and 12 columns.
Claim 54
Dependent Claim
15 words
The biological chip plate of claim 41 wherein the probes are DNA or RNA molecules.
Claim 55
Dependent Claim
19 words
The biological chip plate of claim 51 wherein the DNA or RNA molecules comprise sequences directed to pathogenic organisms.
Claim 56
Dependent Claim
13 words
The biological chip plate of claim 52 wherein the pathogenic organism is HIV.
Claim 57
Dependent Claim
19 words
The biological chip plate of claim 51 wherein the DNA or RNA molecules comprise sequences directed to human DNA.
Claim 58
Dependent Claim
28 words
The biological chip plate of claim 52 wherein the sequences are directed to a human gene variant that indicates the existence of or predisposition to a genetic disease.
Claim 59
Dependent Claim
18 words
The biological chip plate of claim 55 wherein the disease is cystic fibrosis, diabetes, muscular dystrophy or cancer.
Claim 60
Dependent Claim
19 words
The biological chip plate of claim 41 wherein the probe arrays each of the test wells are the same.
Claim 61
Dependent Claim
32 words
The biological chip plate of claim 41 wherein the test wells are arranged in rows and columns and the rows contain the same probe array and the columns contain different probe arrays.
Claim 62
Dependent Claim
16 words
The biological chip plate of claim 41 wherein the probe arrays comprise at least 1000 features.
Claim 63
Dependent Claim
16 words
The biological chip plate of claim 41 wherein the probe arrays comprise at least 10,000 features.
Claim 64
Dependent Claim
16 words
The biological chip plate of claim 41 wherein the probe arrays comprise at least 100,000 features.
Claim 65
Dependent Claim
16 words
The biological chip plate of claim 41 wherein the probe arrays comprise at least 1,000,000 features.
Claim 66
Independent Claim
91 words
A method for making a biological chip plate comprising the steps of providing a contiguous substrate and a body, the contiguous substrate that comprises a contiguous surface and, attached to the contiguous surface, a plurality of probe arrays, and the body comprising a plurality of channels; and attaching the body to the surface of the contiguous substrate whereby a plurality of the channels each cover a probe array and the surface of the substrate closes one end of the plurality of channels, thereby forming test wells defining spaces for receiving samples.
Claim 67
Independent Claim
91 words
A method for making a biological chip plate comprising the steps of providing a contiguous substrate and a body, the contiguous substrate that comprises a contiguous surface and, attached to the contiguous surface, a plurality of probe arrays, and the body comprising a plurality of channels; and attaching the body to the surface of the contiguous substrate whereby a plurality of the channels each cover a probe array and the surface of the substrate closes one end of the plurality of channels, thereby forming test wells defining spaces for receiving samples.
Claim 68
Dependent Claim
13 words
The method of claim 63 wherein the probes are DNA or RNA molecules.
Claim 69
Dependent Claim
55 words
A wafer comprising a contiguous substrate that comprises a contiguous surface and, attached to the contiguous surface, a plurality of probe arrays, wherein the probe arrays are arranged on the wafer surface in rows and columns, wherein the probe arrays in each row are the same and the probe arrays in each column are different.
Claim 70
Dependent Claim
55 words
A wafer comprising a contiguous substrate that comprises a contiguous surface and, attached to the contiguous surface, a plurality of probe arrays, wherein the probe arrays are arranged on the wafer surface in rows and columns, wherein the probe arrays in each row are the same and the probe arrays in each column are different.
Claim 71
Dependent Claim
13 words
The wafer of claim 65 wherein the probes are DNA or RNA molecules.
Claim 72
Dependent Claim
15 words
The wafer of claim 66 wherein the DNA or RNA molecules comprise sequences of HIV.
Claim 73
Dependent Claim
21 words
The wafer of claim 66 wherein the probe arrays in the columns comprise sequences for screening a plurality of genetic diseases.
Claim 74
Dependent Claim
17 words
The wafer of claim 68 wherein the genetic diseases comprise cystic fibrosis, diabetes, muscular dystrophy or cancer.
Claim 75
Dependent Claim
37 words
The method of claim 28 wherein said arrays of probes are made by repeating the steps of: (a) selectively directing light at said surface to remove photoremovable protecting groups; and (b) selectively coupling monomers to said surface.
Claim 76
Dependent Claim
15 words
The system of claim 30 wherein the probe arrays are produced by light-directed probe synthesis.
Claim 77
Dependent Claim
17 words
The biological chip plate of claim 41 wherein the probe arrays are produced by light-directed probe synthesis.
Claim 78
Dependent Claim
15 words
The method of claim 63 wherein the probe arrays are produced by light-directed probe synthesis.
Claim 79
Dependent Claim
15 words
The wafer of claim 69 wherein the probe arrays are produced by light-directed probe synthesis.
References Cited (Backward Citations)
US5348855A
Cited
US5424186A
Cited
US5143854A
Cited
WO1990015070A1
Cited
US5196305A
Cited
WO1992010092A1
Cited
US5384261A
Cited
US5288514A
Cited
WO1994012305A1
Cited
US5382512A
Cited
US5571639A
Cited
US5538857A
Cited
US5578832A
Cited
US5556752A
Cited
US5545531A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-02-22 | 2002-08-24 | 2003-02-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-02-22 | 2006-08-24 | 2007-02-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-02-22 | 2010-08-24 | 2011-02-23 | $7700.00 | Window Closed / Lapsed |